288 related articles for article (PubMed ID: 20171417)
21. Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable.
Duncan EJ; Woolson SL; Hamer RM
Int Clin Psychopharmacol; 2012 Sep; 27(5):283-90. PubMed ID: 22644368
[TBL] [Abstract][Full Text] [Related]
22. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia.
Bhanji NH; Chouinard G; Margolese HC
Eur Neuropsychopharmacol; 2004 Mar; 14(2):87-92. PubMed ID: 15013023
[TBL] [Abstract][Full Text] [Related]
23. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
24. Maintenance treatment with long-acting injectable risperidone in first-episode schizophrenia: a randomized effectiveness study.
Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa-McMillan A
J Clin Psychiatry; 2012 Sep; 73(9):1224-33. PubMed ID: 22938760
[TBL] [Abstract][Full Text] [Related]
25. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department, Hospital Tengku Ampuan Rahimah, Selangor, Malaysia.
Ponto T; Ismail NI; Abdul Majeed AB; Marmaya NH; Zakaria ZA
Methods Find Exp Clin Pharmacol; 2010; 32(6):427-32. PubMed ID: 20852752
[TBL] [Abstract][Full Text] [Related]
26. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
Girardi P; Serafini G; Pompili M; Innamorati M; Tatarelli R; Baldessarini RJ
Pharmacopsychiatry; 2010 Mar; 43(2):66-72. PubMed ID: 20099224
[TBL] [Abstract][Full Text] [Related]
27. Clinical review of a long-acting, injectable formulation of risperidone.
Knox ED; Stimmel GL
Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.
Ren XS; Crivera C; Sikirica M; Dirani R; Qian S; Kazis LE
J Clin Pharm Ther; 2011 Jun; 36(3):383-9. PubMed ID: 21062329
[TBL] [Abstract][Full Text] [Related]
30. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
Taylor DM; Young CL; Mace S; Patel MX
J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
[TBL] [Abstract][Full Text] [Related]
31. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
32. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
Rossi A; Bagalà A; Del Curatolo V; Scapati F; Bernareggi MM; Giustra MG;
Hum Psychopharmacol; 2009 Oct; 24(7):574-83. PubMed ID: 19790173
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting.
Kim B; Lee SH; Choi TK; Suh S; Kim YW; Lee E; Yook KH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1231-5. PubMed ID: 18442879
[TBL] [Abstract][Full Text] [Related]
34. Risperidone long-acting therapy prescribing patterns and their impact on early discontinuation of treatment in a large Medicaid population.
Boaz TL; Constantine RJ; Robst J; Becker MA; Howe AM
J Clin Psychiatry; 2011 Aug; 72(8):1079-85. PubMed ID: 21034690
[TBL] [Abstract][Full Text] [Related]
35. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
[TBL] [Abstract][Full Text] [Related]
36. Risperidone long-acting injection: a prospective 3-year analysis of its use in clinical practice.
Taylor DM; Fischetti C; Sparshatt A; Thomas A; Bishara D; Cornelius V
J Clin Psychiatry; 2009 Feb; 70(2):196-200. PubMed ID: 19026261
[TBL] [Abstract][Full Text] [Related]
37. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
38. Treatment effectiveness and adherence in patients with schizophrenia treated with risperidone long-acting injection.
Chang CL; Tzeng DS; Lung FW
Psychiatry Res; 2010 Nov; 180(1):16-9. PubMed ID: 20488552
[TBL] [Abstract][Full Text] [Related]
39. Switching from depot antipsychotics to risperidone: results of a study of chronic schizophrenia. The Schizophrenia Treatment & Assessment Group.
Desai NM; Huq Z; Martin SD; McDonald G
Adv Ther; 1999; 16(2):78-88. PubMed ID: 10539380
[TBL] [Abstract][Full Text] [Related]
40. Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome.
Taylor DM; Young C; Patel MX
Int J Neuropsychopharmacol; 2006 Dec; 9(6):685-94. PubMed ID: 16939663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
